AMD Patients Undergoing Anti-VEGF Treatment May Be At Risk For Ocular Complications

A longitudinal study by researchers at Duke University suggests individuals who receive anti-vascular endothelial growth factor (VEGF) treatment for age-related macular degeneration (AMD) are at a higher risk of having ocular complications.